Experience in the treatment of hemorrhagic complications in a patient with a new coronavirus infection on the background of anticoagulant therapy

A 73 - year - old patient with COVID-19, on the 9th day from the start of treatment, against the background of anticoagulant therapy, developed a complication in the form of the spontaneous formation of a hematoma of pre - vesicular tissue with spread to the tissue of the retroperitoneal space. During an emergency operation, a source of bleeding was found - an artery of the bladder wall. In the postoperative period, glucocorticoid therapy, antibiotic therapy, respiratory support, symptomatic treatment were continued. Contrary to temporary guidelines for preventing, diagnosing, and treating COVID-19, anticoagulant drugs were canceled, and repeated transfusions of blood plasma and erythrocyte mass were performed to replenish blood loss and correct the deficiency of coagulation factors. Against the treatment background, the patient recovered. On the 22nd day, the patient was discharged in a satisfactory condition.

COVID-19, COVID-19, complications of anticoagulant therapy, surgical treatment of hemorrhagic complications